Drug industry marketing, a long controversial aspect of a physicians' practice and life, may perhaps be experiencing its tightest guidelines yet. Dr. Joseph Heyman, chair of the American Medical Association board of trustees, tells host Bruce Japsen about his thoughts on the new voluntary pharmaceutical industry guidelines on marketing and gift-giving to physicians, signifynig a departure from prior practices.
Thoughts on New Pharma Marketing Guidelines
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Drug industry marketing, a long controversial aspect of a physicians' practice and life, may perhaps be experiencing its tightest guidelines yet. Dr. Joseph Heyman, chair of the American Medical Association board of trustees, tells host Bruce Japsen about his thoughts on the new voluntary pharmaceutical industry guidelines on marketing and gift-giving to physicians, signifynig a departure from prior practices.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Phase 3 study results of plozasiran in patients with FCS
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
FINE-HEART Pooled Analysis
NYHA FC and Finerenone Response: Clinical Trial Insights
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?